SpringWorks Therapeutics (SWTX)
(Real Time Quote from BATS)
$30.40 USD
-0.05 (-0.16%)
Updated Oct 15, 2024 10:06 AM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Price, Consensus and EPS Surprise
SWTX 30.40 -0.05(-0.16%)
Will SWTX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for SWTX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SWTX
Why Is Fate Therapeutics (FATE) Up 18.7% Since Last Earnings Report?
Why Is SpringWorks Therapeutics (SWTX) Up 11.7% Since Last Earnings Report?
SWTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Predict a 61.05% Upside in SpringWorks Therapeutics (SWTX): Here's What You Should Know
SWTX's NDA for Rare Tumor Drug Gets Priority Review From FDA
Here's Why You Should Invest in SpringWorks (SWTX) Stock Now
Other News for SWTX
Deep Track Capital's Strategic Investment in Reneo Pharmaceuticals
SpringWorks Therapeutics Inc (SWTX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Deep Track Capital, LP Increases Stake in Guardant Health Inc
Deep Track Capital, LP Increases Stake in Guardant Health Inc
BOXER CAPITAL, LLC Acquires New Stake in Instil Bio Inc